#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperoxaluria Staphylococcal infection Renal cancer metastatic Acute lymphocytic leukaemia recurrent Hyperchylomicronaemia Non-Hodgkin's lymphoma unspecified histology indolent Autoimmune myositis Head and neck cancer Deafness bilateral Malignant glioma CDKL5 deficiency disorder Hereditary spastic paraplegia Oesophageal carcinoma Nodal marginal zone B-cell lymphoma Cutaneous T-cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Angiosarcoma – Treatment Lymphatic malformation – Treatment Osteosarcoma metastatic Ewing’s sarcoma – Basic Information Leiomyosarcoma recurrent Alveolar rhabdomyosarcoma Haemolytic uraemic syndrome – Trials in Disease Focal segmental glomerulosclerosis – Trials in Disease Focal segmental glomerulosclerosis Carcinoid syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Odevixibat Levocetirizine Dihydrochloride Isoleucine Dobutamine Hydrochloride Finerenone Mirtazapine Tafasitamab POTASSIUM CLAVULANATE Tetracosactide Pemetrexed Fludarabine Phosphate Ph. Eur. Tomligisiran Ttx-030 Ecoo4 Ck-0045 Candesartan PIROXICAM Isavuconazonium Sulfate Somatostatin Tucidinostat More therapies…

    Learn about Your Condition

    Cholecystitis acute Gastrointestinal disorder Eyelid ptosis Polycystic ovarian syndrome Cholangiocarcinoma Weaning failure Hypotonia Cerebral haemorrhage Monogenic diabetes Pterygium Eye disorder Asplenia Bacterial vaginosis Schizophreniform disorder Systemic infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Comparing Sotorasib and Pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Hydroxocobalamin
    • Calcium Folinate
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study of intranasal insulin to prevent delirium in patients aged 65 years or older following elective cardiac surgery

    Recruiting

    4 1 1
    Investigated Diseases:
    • Delirium
    Investigated Drugs:
    • Insulin Human
    • Sodium Chloride
    The Netherlands

  • Evaluating the effect of semaglutide on wound healing in patients with diabetic foot ulcers

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Semaglutide
    The Netherlands

  • A study to evaluate the safety and effectiveness of AZD9750 and saruparib in patients with metastatic prostate cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Saruparib
    The Netherlands Spain

  • A study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure

    Recruiting

    3 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    Denmark Germany Poland Spain

  • Study to evaluate the effect of omaveloxolone on mitochondrial function in patients with Friedreich’s ataxia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Friedreich’s ataxia
    Investigated Drugs:
    • Omaveloxolone
    Czechia Poland
Previous Page
1 … 35 36 37 38 39 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!